| Financial Year |
March 31 2023 |
| Monetary Funds |
123,919,309.64 |
| Held-for-trading Financial Assets |
1,511,323.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
4,770,909.59 |
| Advances to Suppliers |
43,441,237.80 |
| Other Receivables |
21,880,401.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
44,367,041.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,719,956.94 |
| Total Current Assets |
344,587,935.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
760,198,743.09 |
| Investment Properties |
57,886,426.53 |
| Fixed Assetes |
996,094,461.88 |
| Under-construction Projects |
2,527,315,289.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,732,402,821.94 |
| R&D expenses |
-- |
| Goodwill |
194,337,106.57 |
| Long-Term Deferred and Prepaid Expenses |
9,713,506.38 |
| Deferred Income Tax Assets |
88,956,303.45 |
| Other Non-Current Assets |
171,520,175.02 |
| Sub-Total of Non-Current Assets |
7,539,650,138.60 |
| Total Assets |
7,884,238,073.87 |
| Short-Term Loans |
202,746,626.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
641,237,130.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,014,807.58 |
| Taxes Payable |
38,765,453.87 |
| Interest Payable |
-- |
| Dividend Payable |
19,285,710.00 |
| Other payables |
1,413,369,337.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,187,222.51 |
| Other Current Liabilities |
19,566,505.25 |
| Sub-Total of Current Liabilities |
2,533,398,662.50 |
| Long-term Loans |
837,173,035.63 |
| Bonds Payable |
779,781,339.80 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
73,857,380.33 |
| Deferred Income Tax Liabilities |
376,512,637.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,069,918,910.27 |
| Total Liabilities |
4,603,317,572.77 |
| Paid-In Capital(Or Share Stock) |
1,117,647,872.00 |
| Capital Surplus |
269,322,402.16 |
| Surplus Reserve |
309,491,132.58 |
| LESS:Treasury Stock |
66,240,000.00 |
| Undistributed Profits |
1,128,879,062.20 |
| Minority Stockholder's Interest |
363,744,579.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,917,175,922.07 |
| Owner's Equity（Stockholder's Equity） |
3,280,920,501.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,884,238,073.87 |
